Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LF3W
|
|||
| Former ID |
DNC002282
|
|||
| Drug Name |
ISIS 138678
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Helicase-moi messenger RNA (DICER1 mRNA) | Target Info | . | [1] |
| KEGG Pathway | MicroRNAs in cancer | |||
| Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | |||
| WikiPathways | mRNA Processing | |||
| Hypoxia-mediated EMT and Stemness | ||||
| RNA interference | ||||
| miRNA Biogenesis | ||||
| Regulatory RNA pathways | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 7,427,470, Antisense modulation of helicase-moi expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.